Invitrogen’s Sale of BioReliance Topped Most-Read GenomeWeb News Stories Last Week

Feb 19, 2007

NEW YORK (GenomeWeb News) - What are GenomeWeb News subscribers reading? Below are the five most-read articles for the five-day period ended Friday, Feb. 16.

1. Invitrogen to Sell BioReliance for $210M; Posts Weak Revenue Gain and $100M Loss in Q4 (from Feb. 14)

2. House Bill Seeks to Prohibit 'All' New Human Genome Patenting (from Feb. 16)

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Closely Intertwined

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Little From Here and There

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

All the Arms for Hugging

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

This Week in Science

In Science this week: in vitro generation of human reproductive cells, and more.

Main menu